$CELG Recent News Is the next Cisco out there? 3:24

New Post Public Reply Private Reply Replies (0) Message Board

Dec 5, 2014 at 12:17 PM

$CELG Recent News

Is the next Cisco out there? 3:24 p.m. Nov. 25, 2014 - The Trading Deck
5 charts show how stock repurchases boost prices 6:00 a.m. Nov. 18, 2014 - Ophir Gottlieb
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
Celgene profit up 37%, raises outlook 7:42 a.m. Oct. 23, 2014 - MarketWatch.com
Be ready to play another market surge 11:25 a.m. Sept. 19, 2014 - The Trading Deck
14 stocks loved by top-performing fund managers 5:49 a.m. Sept. 18, 2014 - Philip van Doorn
Lululemon surges; RadioShack rebounds 2:24 p.m. Sept. 11, 2014 - Sue Chang
Major U.S. benchmarks rattle cage on first support 10:06 a.m. Sept. 10, 2014 - Michael Ashbaugh
Celgene shares up on news of positive late-stage drug trial 6:42 a.m. Sept. 4, 2014 - Ciara Linnane
How retail sector sets up stocks at the end of summer 2:32 p.m. Aug. 14, 2014 - The Trading Deck
S&P 500 retests the breakdown point 10:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
S&P 500 ekes out another record close: stock market live blog recap 3:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 10:44 a.m. July 24, 2014 - Russ Britt
Biogen results crush consensus 3:55 p.m. July 23, 2014 - The Trading Deck
Nasdaq needs to turn up the volume 10:59 a.m. July 17, 2014 - The Trading Deck
Bull rolls on, but opportunities start to dwindle 12:52 p.m. July 10, 2014 - The Trading Deck
Reynolds rises on buyout report; Delta gains altitude 1:25 p.m. July 9, 2014 - Sue Chang
Celgene's arthritis drug fails a test, but company's stock rises anyway 12:23 p.m. July 9, 2014 - Russ Britt
Celgene shares slump as late-stage trial misses goal 6:27 a.m. July 9, 2014 - Ciara Linnane

'Mad Money' Lightning Round: Buy, Buy, Buy Texas Instruments 6:00 a.m. Today - TheStreet.com
Cramer's Lightning Round - Constellation Brands Has Real Magic (12/4/14) 4:36 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Google Is Better Than the Market Thinks 8:31 p.m. Dec. 4, 2014 - TheStreet.com
Jim Cramer Picks 19 Companies That Should Get Acquired in 2015 2:00 p.m. Dec. 4, 2014 - TheStreet.com
Acetylon Begins Phase 2 Study Of Ricolinostat With Pomalyst 8:08 a.m. Dec. 4, 2014 - benzinga.com
Cramer's Mad Money - PVH Fits Well At A Discount (12/3/14) 6:04 a.m. Dec. 4, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Cyclical Stocks Are Fund Manager Picks Now 8:36 p.m. Dec. 3, 2014 - TheStreet.com
'Mad Money' Lightning Round: You're on Your Own With Tesla 6:00 a.m. Dec. 3, 2014 - TheStreet.com
Jim Cramer's Top Stock Picks: REGN BMRN ISIS EOG BIIB CELG DECK ZOES 6:00 a.m. Dec. 3, 2014 - TheStreet.com
Cramer's Lightning Round - Power To The PPL (12/2/14) 5:46 a.m. Dec. 3, 2014 - Seeking Alpha
Cramer's Mad Money - Deckers Is About More Than Just Uggs (12/2/14) 5:33 a.m. Dec. 3, 2014 - Seeking Alpha
‘Fast Money’ Recap: Can Stocks Still Rally if Oil Prices Rebound? 5:00 a.m. Dec. 3, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Forget Bargain Losers, Look for the 52-Week Winners 8:21 p.m. Dec. 2, 2014 - TheStreet.com
Top Funds Gobble Up Tech And Medical Stocks 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Cramer: Cypress Semiconductor Merger With Spansion Is ‘Fantastic’ 11:27 a.m. Dec. 2, 2014 - TheStreet.com
Jim Cramer's Five Best Stock Picks for the Biotech Sector 11:11 a.m. Dec. 2, 2014 - TheStreet.com
Celgene (CELG) On Momo Momentum Watch Today 9:57 a.m. Dec. 2, 2014 - TheStreet.com
Meet 5 Top Drug Stocks That Are Bolting Past Market 7:02 a.m. Dec. 2, 2014 - Investors Business Daily
'Fast Money' Recap: Energy Companies Ebb and Flow With Oil Prices 5:00 a.m. Dec. 2, 2014 - TheStreet.com
Celgene Recommends Shareholders Reject "Mini-Tender" Offer By TRC Capital Corporation 3:32 p.m. Dec. 1, 2014 - benzinga.com

Critical Alerts For Noodles & Company, Goldcorp, YY, Celgene and LinkedIn Released By InvestorsObserver 9:31 a.m. Dec. 2, 2014 - PR Newswire - PRF
Celgene Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Corporation 4:30 p.m. Dec. 1, 2014 - BusinessWire - BZX
Celgene Receives Positive CHMP Opinion for OTEZLA® (apremilast), the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic Arthritis 6:00 a.m. Nov. 21, 2014 - BusinessWire - BZX
Chef Michael Ferraro, the Pancreatic Cancer Action Network and Meals to Heal Team up with Celgene to Address Nutritional Needs and Challenges Faced by Pancreatic Cancer Patients and Caregivers 8:00 a.m. Nov. 20, 2014 - BusinessWire - BZX
UPDATE: Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Well Tolerated and Increases CD4 Counts in People Living With HIV 4:29 p.m. Nov. 19, 2014 - Marketwired
Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Counts in People Living With HIV 3:35 p.m. Nov. 19, 2014 - Marketwired
Oral OTEZLA® (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active Psoriatic Arthritis 7:30 a.m. Nov. 18, 2014 - BusinessWire - BZX
Moffitt Cancer Center Announces Development of Experimental Treatment for Myelodysplastic Syndromes, Autoimmune Diseases 9:03 a.m. Nov. 17, 2014 - BusinessWire - BZX
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF
Critical Alerts For Alibaba, Bloomin' Brands, VoxelJet, 51job and Celgene Released By InvestorsObserver 9:31 a.m. Nov. 5, 2014 - PR Newswire - PRF
Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress 8:30 a.m. Oct. 31, 2014 - BusinessWire - BZX
New Medicare Plan, Clinical Study Results, ANDA Filing Confirmation, Strategic Collaboration, and Merger Termination - Research Reports on UnitedHealth, Celgene, Actavis, Bristol-Myers Squibb and Salix 9:10 a.m. Oct. 22, 2014 - PR Newswire - PRF
Phase II Data in Crohn’s Disease for Celgene’s Oral Antisense Therapy GED-0301 to Be Presented at UEG Week 2014 7:35 a.m. Oct. 20, 2014 - BusinessWire - BZX
Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene 9:10 a.m. Oct. 15, 2014 - PR Newswire - PRF
Acquisition, Market Activity, and Upcoming Events - Research Reports on Auxilium, Lakeland, Endo, Actavis and Celgene 8:30 a.m. Oct. 14, 2014 - PR Newswire - PRF
New Analyses of Oral OTEZLA® (Apremilast) Presented at EADV Show Efficacy in Difficult-to-Treat Areas of Moderate to Severe Plaque Psoriasis 8:38 a.m. Oct. 10, 2014 - BusinessWire - BZX
Oral OTEZLA® (apremilast) Data Presented at EADV Show Improved Measures of Health-Related Quality of Life and Work Productivity in Patients with Moderate to Severe Plaque Psoriasis 8:37 a.m. Oct. 10, 2014 - BusinessWire - BZX
Critical Alerts For Exxon Mobil, Celgene, Verizon, Intercept Pharmaceuticals and Lockheed Martin Released By InvestorsObserver 9:31 a.m. Oct. 8, 2014 - PR Newswire - PRF
Celgene to Present Long-Term Efficacy and Safety Data on Oral OTEZLA® (apremilast) in Plaque Psoriasis and Psoriatic Arthritis at European Academy of Dermatology and Venereology Congress 7:30 a.m. Oct. 7, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR Bolsters Robotics Edge with Key Academic Partnerships

Let’s talk about what’s cooking in the robotics world, where FF EAI Robotics Ecosystem (NASDAQ: FFR), a heavyweight in the AI robotics ring, is shaking hands with academic giants to fast-track innovation. On November 4, 2026, FFR revealed a strategic alliance with two academic powerhouses—the California Science and Technology University (CSTU) and the Boston...

GomSpace Eyes SEK 1.6 Billion Revenue by 2030

Cracking Open GomSpace's Q3 Gains You don't just stumble upon profitability in this market; that's for sure. GomSpace, however, seems to have a knack for finding its stride amidst the chaos. In their latest earnings report, it looks like they're not just coasting—they're powering through with profitable growth in the third quarter. Who would have thought? These folks...

Choosing Lakefront Flooring: A Practical Guide for Owners

Understanding Lakefront Challenges Owning a lakefront rental sounds like a dream, right? But the reality involves a mixed bag of conditions that can chew up flooring faster than a pair of puppy claws on exposed oak. We're talking about moisture, sand, and constant guest traffic making these properties a hot mess if you're not careful. Waterproof Vinyl: The Smart Bet...

Globee® AI Awards Calls For Global Innovation Entries

Rolling Out the Red Carpet for AI Innovators Worldwide Here's a call to all the boundary-pushing eggheads tinkering with artificial intelligence. The Globee® Awards is opening its doors again for the 3rd Annual AI showdown, inviting nominations from the creative minds conjuring up AI magic across the globe. This ain't your grandma's science fair; we're talking real-world...

I-CAR Commends Excellence in Collision Repair Education

Spotlighting Integrity and Leadership in Collision Repair You don't often see discussions about car repair lighting up the room, but here we are. At the 2026 SEMA Show in Las Vegas, I-CAR really turned heads by honoring those steadfast pros who've stuck their necks out to ensure the collision repair industry thrives. Justin Lewis and Victor Auto Body Works have been...

LexisNexis Tackles AI Agents: Risk Management Game Changer

When you think of managing digital risk, AI agents probably weren't on your radar mere months ago. But now, LexisNexis Risk Solutions is diving headlong into this new frontier with their Know Your Agent intelligence. Trust me, they're not playing around. They're making a big splash in handling what they call 'agentic activity.' That's AI speak for all those chatbot-like...

Small Dogs, Big Findings: Hill's Pet Nutrition's Study

The Growing Importance of Small Dogs Small dogs have weaseled their way into urban living rooms and metropolitan hearts around the world. Hill's Pet Nutrition pulled back the curtain on the underestimated world of these pint-sized companions with their latest 'World of the Small Dog' report. As these furry bundles surge in popularity—thanks to tighter living spaces and...

GAC Hits Record with 223,000 Units Exported in 2026

GAC Gaining Ground Globally in 2026 China's GAC is making waves with its recent export figures. They've blitzed past the competition, exporting 223,000 units from January to October 2026. That's not just a number, it’s a record, with October alone seeing a hefty 26,017 units shipped—marking an impressive 80.8% growth compared to last year. A Strategic Push in Europe...

ePlus Schedules Q2 2027 Earnings Call Amid Corrections

Earnings Date: Mark Your Calendar Well, folks, the date is set. ePlus Inc. is gearing up to drop some numbers that could stir the markets a bit. Come November 5th, those eagle-eyed investors better be on their toes because that’s when we’re getting the scoop on ePlus' second-quarter results for the fiscal year 2027. The bell rings after the market closes, so pour...

Ryde Group Faces Fraud Claims: Investor Action Looms

Big Trouble in the Stock Market for Ryde Group Well, hold onto your hats, folks—Ryde Group Ltd. is neck-deep in legal hot water. If you thought the stock market was a place of pure strategy and devoid of any drama, think again. Recently, DJS Law Group threw down the gauntlet with a class action lawsuit against Ryde Group (NYSE American: RYDE) for some pretty hefty...